EXTON, PA -- (MARKET WIRE) -- January 25, 2007 -- Rheologics, Inc., a subsidiary of Rheologics Technologies, Inc. (PINKSHEETS: RTGI) (“Rheologics”), the leader in the study of blood viscosity and its relationship to cardiovascular disease, is pleased to announce that its Laboratory Services unit has received an encouraging number of requests for its Whole Blood Viscosity (WBV) testing program. The Company believes that in addition to gathering important clinical data, the initial response indicates a strong demand for the service.
